Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN(FIM)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorShenzhen Pulsecare Medical Technology Co., Ltd.

About this trial

This study is a prospective and exploratory clinical study, enrolling patients with essential hypertension. This study is planned to be conducted in 2 research institutions in China, and a total of 6 subjects are planned to be included. After the subjects sign the informed consent form (ICF) approved by the ethics committee, they will enter the screening procedure. Subjects who meet the inclusion criteria and do not meet any of the clinical exclusion criteria will be enrolled after undergoing renal artery CTA angiography.

All patients will undergo clinical evaluation and blood pressure measurement during the operation, at the time of discharge, and at 1 month, 2 months, 3 months, and 6 months after the operation.

It is recommended that the anti-hypertensive medications used before the operation should not be changed within 6 months after the operation for the cases. When the systolic blood pressure (SBP) is ≥ 180 mmHg or there are clinical symptoms caused by hypertension, the drug dosage should be increased as a priority, and then the anti-hypertensive medications should be adjusted. When the systolic blood pressure (SBP) is ≤ 120 mmHg or there are clinical symptoms caused by a decrease in blood pressure, the anti-hypertensive medications should be reduced.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Ultrasonic Nerve Ablation System

    Procedure/Surgery

    Treatment of patients with essential hypertension using the ultrasonic nerve ablation system

Treatment groups

6 Participants
are divided into 1 treatment group
Group A: Exploratory Clinical Study of the Ultrasound Nerve Ablation SystemExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

The change in the average daytime systolic blood pressure two months after the operation

That is, the difference between the average daytime (from 7:00 to 22:00) systolic blood pressure measured before the operation and the average daytime systolic blood pressure measured during the follow-up visit two months after the operation

Time frame
Two months after the operation
2

Major adverse events within 30 days after the operation

Major adverse events include: all-cause mortality, renal complications, renal artery embolism events, complications of interventional treatment, hypertensive/hypotensive crises during hospitalization, and major cardiovascular and cerebrovascular complications.

Time frame
Within 30 days after the operation

Secondary outcomes

1

The changes in the average systolic blood pressure of ambulatory blood pressure during the daytime, at night and over 24 hours after the operation

Changes in the average systolic blood pressure of ambulatory blood pressure during the daytime, at night and over 24 hours after the operation (1 month, 3 months, 6 months) That is, the difference between the average systolic blood pressure of ambulatory blood pressure measured during the daytime (7:00-22:00), at night (22:00-7:00) and over 24 hours before the operation and the average systolic blood pressure of ambulatory blood pressure measured during the daytime, at night and over 24 hours during the postoperative follow-up.

Time frame
1 month, 3 months, 6 months after the operation
2

Changes in the average diastolic blood pressure of ambulatory blood pressure during the daytime, at night and over 24 hours after the operation

That is, the difference between the average diastolic blood pressure of ambulatory blood pressure measured during the daytime (7:00-22:00), at night (22:00-7:00) and over 24 hours before the operation, and the average diastolic blood pressure of ambulatory blood pressure measured during the daytime, at night and over 24 hours during the postoperative follow-up

Time frame
1 month, 2 months, 3 months, 6 months after the operation
3

The attainment rate of systolic blood pressure reaching the standard in the outpatient clinic after the operation

That is, the proportion of subjects whose systolic blood pressure measured in the outpatient clinic during the postoperative follow-up is less than 140 mmHg.

Time frame
1 month, 2 months, 3 months, 6 months after the operation
4

The change in systolic blood pressure measured in the outpatient clinic after the operation

That is, the difference between the systolic blood pressure measured in the outpatient clinic before the operation and the systolic blood pressure measured in the outpatient clinic during the postoperative follow-up

Time frame
1 month, 2 months, 3 months, 6 months after the operation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.